Low molecular weight heparin for protein S deficiency in pregnancy
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial tests whether a blood-thinning medicine (low molecular weight heparin) can improve pregnancy outcomes in women with protein S deficiency, a condition that raises the risk of blood clots. The goal is to see if this treatment helps prevent pregnancy complications caused by clots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have protein S deficiency (confirmed by a blood test when not pregnant, or by genetic testing).
- You are pregnant or have given birth between August 2024 and October 2027.
- You have had a blood clot in the past (especially before age 50, in an unusual site, or repeated episodes) or a new clot during this pregnancy.
- At least one family member has similar symptoms (like clots or protein S deficiency).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the best way to manage blood thinners (like injections of LMWH) during pregnancy for people who need them because of a past or current blood clot risk. It may help by improving how safely and effectively anticoagulation is handled to reduce clot complications.
This trial tests whether a blood-thinning medication (enoxaparin) can help prevent complications like preterm birth or preeclampsia from happening again. It is for people who had a past pregnancy problem tied to placenta blood flow issues.
This study looks at how people’s blood and clotting behave during pregnancy when taking a specific blood thinner called low molecular weight heparin (LMWH) three times a day. It may help doctors fine-tune how safely and effectively LMWH is used during pregnancy.
This trial tests whether adding a daily blood-thinning injection (heparin) to low-dose aspirin helps prevent preeclampsia better than aspirin alone for pregnant women at high risk.
This trial studies whether taking acetyl salicylic acid (aspirin) during pregnancy can reduce problems caused by chronic high blood pressure. It focuses on pregnant people already known to have high blood pressure before or early in pregnancy.
This study looks at how blood clotting changes during pregnancy and how a common blood thinner affects clotting in the lab. It may help doctors understand pregnancy-related clotting risks better.
Hear when a new Pregnancy Related trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.